LinQNotes
Giving life sciences teams the power to explore
unstructured clinical data, discover the “why”
behind treatment decisions, and uncover directional
insights – faster.
Over 80% of meaningful patient context is buried in unstructured clinical notes.
Traditional tools lack the flexibility and depth to reveal the full picture behind treatment decisions, disease progression, and access barriers.
To truly understand patient journeys, life sciences teams need more than just structured data.
To truly understand patient journeys, life sciences teams need more than just structured data.
LinQNotes is an exploratory tool that allows users to search and interact with unstructured clinical data.
Explore detailed data contained within physician notes, imaging reports, dictations, and discharge summaries.
Quickly test hypotheses, identify patterns, and explore the “why” behind real-world data—without the need for structured data pipelines or heavy analytics lift.
Turn hidden insights into action.
Enter your email to learn more or get started today.
LinQNotes is not a traditional analytics tool – it’s your early signal detector, hypothesis validator, and exploratory companion for market-shaping questions.
Clarity from Complexity
Access rich, clinical nuance with ease.
Speed to Insight
Natural language search unlocks context in seconds.
Real-World Ready
Built with pharma workflows and evidence needs in mind.
Built for Exploration
Intuitive search across unstructured and structured data
Natural language querying—no NLP experience required
Filterable by metadata (specialty, date range, note type)
Linked to patient journeys and structured RWD within IHD
De-identified, longitudinal patient-level notes
Purpose-built for exploratory workflows, not just QA validation
How LinQNotes Empowers Teams:
HEOR & RWE
Extract patient-level insights from unstructured clinical notes to uncover relevant study parameters, assess treatment impact, and identify real-world gaps in care.
Commercial & HCP Targeting
Uncover prescribing behaviors, biomarker expressions, and treatment adoption trends to refine commercial strategies and outreach.
Market Access & Barriers to Treatment
Identify where access challenges arise—from diagnostic delays to reimbursement hurdles—and support payer engagement with real-world clinical data.
Medical Affairs & Pharmacovigilance
Identify patterns in physician attitudes and catch early signs of adverse events to support field teams and pharmacovigilance efforts.
